US Patent Issued to SYNAPHARM INDUSTRIAL SYNTHESIS on Aug. 12 for "Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder" (Belgian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,520, issued on Aug. 12, was assigned to SYNAPHARM INDUSTRIAL SYNTHESIS (Alleur, Belgium).

"Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder" was invented by Philippe Danhier (Audregnies, Belgium) and Pascale Azzam (Alleur, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention pertains to a compound and a composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder."

The patent was filed on May 12, 2020, under Application No. 17/610,366.

*For further information, including images, charts and tables, please visit: http://patft.usp...